Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Increased CMV IgG Antibody Titer is Associated with Non-AIDS Events among Virologically Suppressed HIV-Positive Persons.

Hodowanec AC, Lurain NS, Krishnan S, Bosch RJ, Landay AL.

Pathog Immun. 2019;4(1):66-78. doi: 10.20411/pai.v4i1.255. Epub 2019 Feb 14.

2.

Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.

Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SP, Gianella S, de Oliveira MF, Heaton RK, Grant I, Landay AL, Lurain N; CNS HIV AntiRetroviral Therapy Effects Research (CHARTER) Group.

Clin Infect Dis. 2018 Aug 16;67(5):770-777. doi: 10.1093/cid/ciy170.

3.

Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication.

Cohen T, Williams JD, Opperman TJ, Sanchez R, Lurain NS, Tortorella D.

J Virol. 2016 Nov 14;90(23):10715-10727. doi: 10.1128/JVI.01050-16. Print 2016 Dec 1.

4.

Soluble CD163 But Not Soluble CD14 Is Associated With Cytomegalovirus Immunoglobulin G Antibody Levels in Virologically Suppressed HIV+ Individuals.

Hodowanec A, Williams B, Hanson B, Livak B, Keating S, Lurain N, Adeyemi OM.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):e171-4. doi: 10.1097/QAI.0000000000000841. No abstract available.

PMID:
26569178
5.

Characterization of IL-22 and IL-17 Expressing Leukocytes in the Cervix.

Makinde HM, Lurain N, Bitterman P, Martinson J, Plants J, Landay AL, Spear GT.

Am J Reprod Immunol. 2016 Jan;75(1):42-50. doi: 10.1111/aji.12435. Epub 2015 Oct 13.

PMID:
26459205
6.

The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.

Lurain NS, Hanson BA, Hotton AL, Weber KM, Cohen MH, Landay AL.

AIDS Res Hum Retroviruses. 2016 Feb;32(2):134-43. doi: 10.1089/AID.2015.0169. Epub 2015 Oct 22.

7.

In vitro antiretroviral activity and in vivo toxicity of the potential topical microbicide copper phthalocyanine sulfate.

Styczynski AR, Anwar KN, Sultana H, Ghanem A, Lurain N, Chua A, Ghassemi M, Novak RM.

Virol J. 2015 Aug 30;12:132. doi: 10.1186/s12985-015-0358-5.

8.

Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.

Gagermeier JP, Rusinak JD, Lurain NS, Alex CG, Dilling DF, Wigfield CH, Love RB.

Transpl Infect Dis. 2014 Dec;16(6):941-50. doi: 10.1111/tid.12317. Epub 2014 Dec 10.

PMID:
25491023
9.

Reply to Itzhaki and Klapper.

Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, Bennett DA, Schneider JA.

J Infect Dis. 2014 Mar;209(6):974. doi: 10.1093/infdis/jit666. Epub 2013 Nov 26. No abstract available.

10.

CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

Šedý JR, Bjordahl RL, Bekiaris V, Macauley MG, Ware BC, Norris PS, Lurain NS, Benedict CA, Ware CF.

J Immunol. 2013 Jul 15;191(2):828-36. doi: 10.4049/jimmunol.1300894. Epub 2013 Jun 12.

11.

Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease.

Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, Bennett DA, Schneider JA.

J Infect Dis. 2013 Aug 15;208(4):564-72. doi: 10.1093/infdis/jit210. Epub 2013 May 9.

12.

Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women.

Kuniholm MH, Parrinello CM, Anastos K, Augenbraun M, Plankey M, Nowicki M, Peters M, Golub ET, Lurain N, Landay AL, Strickler HD, Kaplan RC.

PLoS One. 2013 Apr 17;8(4):e61973. doi: 10.1371/journal.pone.0061973. Print 2013.

13.

Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.

Parrinello CM, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt PW, Deeks SG, Hodis HN, Kaplan RC.

J Infect Dis. 2012 Jun 15;205(12):1788-96. doi: 10.1093/infdis/jis276. Epub 2012 Apr 5.

14.

Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.

Weisblum Y, Panet A, Zakay-Rones Z, Haimov-Kochman R, Goldman-Wohl D, Ariel I, Falk H, Natanson-Yaron S, Goldberg MD, Gilad R, Lurain NS, Greenfield C, Yagel S, Wolf DG.

J Virol. 2011 Dec;85(24):13204-13. doi: 10.1128/JVI.05749-11. Epub 2011 Oct 5.

15.

Cytomegalovirus viraemia in the modern antiretroviral era(*).

Jacobson M, Lurain N, Hunt P.

HIV Med. 2011 Aug;12(7):387-8. doi: 10.1111/j.1468-1293.2010.00899.x. No abstract available.

16.

Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification.

Caliendo AM, Valsamakis A, Bremer JW, Ferreira-Gonzalez A, Granger S, Sabatini L, Tsongalis GJ, Wang YF, Yen-Lieberman B, Young S, Lurain NS.

J Clin Microbiol. 2011 Aug;49(8):2854-8. doi: 10.1128/JCM.00471-11. Epub 2011 Jun 22.

17.

T cell activation predicts carotid artery stiffness among HIV-infected women.

Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Parrinello CM, Hunt P, Deeks SG, Hodis HN.

Atherosclerosis. 2011 Jul;217(1):207-13. doi: 10.1016/j.atherosclerosis.2011.03.011. Epub 2011 Mar 15.

18.

T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.

Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt P, Karim R, Kern DM, Hodis HN, Deeks SG.

J Infect Dis. 2011 Feb 15;203(4):452-63. doi: 10.1093/infdis/jiq071. Epub 2011 Jan 10.

19.

Antiviral drug resistance of human cytomegalovirus.

Lurain NS, Chou S.

Clin Microbiol Rev. 2010 Oct;23(4):689-712. doi: 10.1128/CMR.00009-10. Review.

20.

Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.

Avery RK, Mossad SB, Poggio E, Lard M, Budev M, Bolwell B, Waldman WJ, Braun W, Mawhorter SD, Fatica R, Krishnamurthi V, Young JB, Shrestha R, Stephany B, Lurain N, Yen-Lieberman B.

Transplantation. 2010 Aug 27;90(4):419-26. doi: 10.1097/TP.0b013e3181e94106.

PMID:
20683281
21.

Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis.

Richardson-Harman N, Lackman-Smith C, Fletcher PS, Anton PA, Bremer JW, Dezzutti CS, Elliott J, Grivel JC, Guenthner P, Gupta P, Jones M, Lurain NS, Margolis LB, Mohan S, Ratner D, Reichelderfer P, Roberts P, Shattock RJ, Cummins JE Jr.

J Clin Microbiol. 2009 Nov;47(11):3530-9. doi: 10.1128/JCM.00673-09. Epub 2009 Sep 2.

22.

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

Wohl DA, Kendall MA, Andersen J, Crumpacker C, Spector SA, Feinberg J, Alston-Smith B, Owens S, Chafey S, Marco M, Maxwell S, Lurain N, Jabs D, Benson C, Keiser P, Jacobson MA; A5030 Study Team.

HIV Clin Trials. 2009 May-Jun;10(3):143-52. doi: 10.1310/hct1003-143.

23.

High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169.

Bradley AJ, Lurain NS, Ghazal P, Trivedi U, Cunningham C, Baluchova K, Gatherer D, Wilkinson GW, Dargan DJ, Davison AJ.

J Gen Virol. 2009 Oct;90(Pt 10):2375-80. doi: 10.1099/vir.0.013250-0. Epub 2009 Jun 24.

24.

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.

Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG.

Clin Infect Dis. 2008 May 1;46(9):1455-7. doi: 10.1086/587106.

PMID:
18419454
25.

Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.

Biancotto A, Iglehart SJ, Lisco A, Vanpouille C, Grivel JC, Lurain NS, Reichelderfer PS, Margolis LB.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):453-62. doi: 10.1089/aid.2007.0155.

PMID:
18327985
26.

Introduction to the special issue dedicated to the 11th International CMV and Beta Herpesvirus Workshop.

Weinberg A, Lurain N.

J Clin Virol. 2008 Mar;41(3):173. doi: 10.1016/j.jcv.2007.12.006. No abstract available.

PMID:
18243782
28.

Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Fox-Canale AM, Hope TJ, Martinson J, Lurain JR, Rademaker AW, Bremer JW, Landay A, Spear GT, Lurain NS.

Virology. 2007 Dec 5;369(1):55-68. Epub 2007 Aug 22.

29.

Evaluation of real-time PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification.

Caliendo AM, Ingersoll J, Fox-Canale AM, Pargman S, Bythwood T, Hayden MK, Bremer JW, Lurain NS.

J Clin Microbiol. 2007 Jun;45(6):1723-7. Epub 2007 Apr 4.

30.

Multilaboratory comparison of hepatitis C virus viral load assays.

Caliendo AM, Valsamakis A, Zhou Y, Yen-Lieberman B, Andersen J, Young S, Ferreira-Gonzalez A, Tsongalis GJ, Pyles R, Bremer JW, Lurain NS.

J Clin Microbiol. 2006 May;44(5):1726-32.

31.
32.

Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.

Cheung TC, Humphreys IR, Potter KG, Norris PS, Shumway HM, Tran BR, Patterson G, Jean-Jacques R, Yoon M, Spear PG, Murphy KM, Lurain NS, Benedict CA, Ware CF.

Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13218-23. Epub 2005 Aug 30.

33.

Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis.

Zariffard MR, Novak RM, Lurain N, Sha BE, Graham P, Spear GT.

J Infect Dis. 2005 Jun 1;191(11):1913-21. Epub 2005 Apr 28.

PMID:
15871126
34.

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.

Avery RK, Bolwell BJ, Yen-Lieberman B, Lurain N, Waldman WJ, Longworth DL, Taege AJ, Mossad SB, Kohn D, Long JR, Curtis J, Kalaycio M, Pohlman B, Williams JW.

Bone Marrow Transplant. 2004 Dec;34(12):1071-5.

PMID:
15489872
35.

Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency.

Blackman SC, Lurain NS, Witte DP, Filipovich AH, Groen P, Schleiss MR.

J Pediatr Hematol Oncol. 2004 Sep;26(9):601-5.

PMID:
15342989
36.

HIV type 1 and cytomegalovirus coinfection in the female genital tract.

Lurain NS, Robert ES, Xu J, Camarca M, Landay A, Kovacs AA, Reichelderfer PS.

J Infect Dis. 2004 Aug 1;190(3):619-23. Epub 2004 Jun 30.

37.

Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs.

Baldanti F, Lurain N, Gerna G.

Hum Immunol. 2004 May;65(5):403-9. Review.

PMID:
15172438
38.

Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA.

Caliendo AM, Yen-Lieberman B, Baptista J, Andersen J, Crumpacker C, Schuurman R, Spector SA, Bremer J, Lurain NS.

J Clin Microbiol. 2003 Aug;41(8):3509-13.

39.

Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.

Chou S, Lurain NS, Thompson KD, Miner RC, Drew WL.

J Infect Dis. 2003 Jul 1;188(1):32-9. Epub 2003 Jun 16. Erratum in: J Infect Dis. 2004 Sep 15;190(6):1202.

PMID:
12825168
40.

Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.

Weinberg A, Jabs DA, Chou S, Martin BK, Lurain NS, Forman MS, Crumpacker C; Cytomegalovirus Retinitis and Viral Resistance Study Group; Adult AIDS Clinical Trials Group Cytomegalovirus Laboratories.

J Infect Dis. 2003 Mar 1;187(5):777-84. Epub 2003 Feb 24.

PMID:
12599051
41.

Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.

Isada CM, Yen-Lieberman B, Lurain NS, Schilz R, Kohn D, Longworth DL, Taege AJ, Mossad SB, Maurer J, Flechner SM, Mawhorter SD, Braun W, Gordon SM, Schmitt SK, Goldman M, Long J, Haug M, Avery RK.

Transpl Infect Dis. 2002 Dec;4(4):189-94.

PMID:
12535261
42.

Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients.

Bhorade SM, Lurain NS, Jordan A, Leischner J, Villanueva J, Durazo R, Creech S, Vigneswaran WT, Garrity ER.

J Heart Lung Transplant. 2002 Dec;21(12):1274-82.

PMID:
12490272
43.

Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients.

Wolf DG, Lurain NS, Zuckerman T, Hoffman R, Satinger J, Honigman A, Saleh N, Robert ES, Rowe JM, Kra-Oz Z.

Blood. 2003 Jan 15;101(2):463-5. Epub 2002 Aug 22.

44.

Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.

Lurain NS, Bhorade SM, Pursell KJ, Avery RK, Yeldandi VV, Isada CM, Robert ES, Kohn DJ, Arens MQ, Garrity ER, Taege AJ, Mullen MG, Todd KM, Bremer JW, Yen-Lieberman B.

J Infect Dis. 2002 Sep 15;186(6):760-8. Epub 2002 Aug 28.

PMID:
12198609
45.

Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.

Lurain NS, Weinberg A, Crumpacker CS, Chou S; Adult AIDS Clinical Trials Group-CMV Laboratories.

Antimicrob Agents Chemother. 2001 Oct;45(10):2775-80.

46.

Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma.

Caliendo AM, Schuurman R, Yen-Lieberman B, Spector SA, Andersen J, Manjiry R, Crumpacker C, Lurain NS, Erice A; CMV Working Group of the Complications of HIV Disease RAC, AIDS Clinical Trials Group.

J Clin Microbiol. 2001 Apr;39(4):1334-8.

47.

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Knight DA, Blinder L, Shen J, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS.

Intervirology. 1999;42(5-6):412-8.

PMID:
10702725
48.

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew WL, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C.

Antimicrob Agents Chemother. 2000 Mar;44(3):688-92.

49.

Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates.

Lurain NS, Kapell KS, Huang DD, Short JA, Paintsil J, Winkfield E, Benedict CA, Ware CF, Bremer JW.

J Virol. 1999 Dec;73(12):10040-50.

50.

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS.

Transplantation. 1999 Sep 27;68(6):814-25.

PMID:
10515382

Supplemental Content

Loading ...
Support Center